Anais Elewaut wins 2025 Denise P. Barlow Award

Anais Elewaut, a recent PhD graduate from Anna Obenauf's lab at the Research Institute of Molecular Pathology (IMP), was presented with the Denise P. Barlow Award for her exceptional doctoral research on some cancers’ ability to evade the immune system. The Barlow Award is given in memory of former IMP Group Leader Denise Barlow and a joint initiative of Vienna-based research institutions, chaired by the Center of Molecular Medicine (CeMM).

The Center of Molecular Medicine (CeMM) announced that the 2025 Denise P. Barlow Award is given to Anais Elewaut, a recent PhD graduate from the lab of Anna Obenauf at the IMP. Elewaut studied why T cell-based immunotherapies—which boost the immune system with engineered T cells trained specifically to combat cancer—achieve great results in some patients while unsuccessful in others. Her research showed how cancer cells modify their environment to dampen the immune response and ensure their survival. Elewaut’s groundbreaking PhD thesis now earned her the 2025 Denise P. Barlow Award.

Read more.

Back